Home / Healthcare / Pharmaceutical / Female Sexual Dysfunction Treatment Market
Female Sexual Dysfunction Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug (Flibanserin, Bremelanotide, Ospemifene, Estrogen Therapy, and Others), By Disease (Hypoactive Sexual Desire Disorder (HSDD), Dyspareunia, and Others), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2023-2030
Report Format: PDF | Published Date: Oct, 2024 | Report ID: FBI100850 | Status : PublishedSummary
TOC
Methodology
Market Segmentation
Infographics
- Global
- 2022
- 131